Caricamento...

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options

Pancreatic ductal adenocarcinoma (PDAC), as the most frequent form of pancreatic malignancy, still is associated with a dismal prognosis. Due to its late detection, most patients are ineligible for surgery, and chemotherapeutic options are limited. Tumor heterogeneity and a characteristic structure...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Kabacaoglu, Derya, Ciecielski, Katrin J., Ruess, Dietrich A., Algül, Hana
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6104627/
https://ncbi.nlm.nih.gov/pubmed/30158932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01878
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !